Kiwa Bio-Tech Products Group Corporation announced audited consolidated earnings results for the year ended December 31, 2018. For the period, the company reported total gross revenues reported for 2018 was $30,650,402 compared to $17,270,069 in 2017, an increase of over 77.5%. Total operating income was $2,589,346 for 2018 compared to 1,796,131 in 2017. This represents an increase of $793,215 or 44%.

The company anticipated to achieve gross revenues of more than $39,000,000 in 2019 due to the growth of its sales team throughout the Country of China. The company also expects that its consolidation plan of expenses will increase the earnings per share.